论文部分内容阅读
波替单抗(硼替佐米,bortezomib,Velcade)用于治疗多发性骨髓瘤或套细胞淋巴瘤。新的药物标签更新了药物处方信息,包括对中重度肝损伤患者的剂量调整:初始剂量减少并严密监视。禁忌证包括
Bortezomib (bortezomib, Velcade) is used to treat multiple myeloma or mantle cell lymphoma. The new drug label updated drug prescription information, including dose adjustments for patients with moderate to severe liver injury: reduced initial dose and close surveillance. Contraindications include